Pharmaceutical firm Ranbaxy Laboratories' revenues are seen going up by 27 percent year-on-year to Rs 2,656 crore in the third quarter of current calendar year.
first published: Nov 8, 2012 07:36 am
A collection of the most-viewed Moneycontrol videos.

Live: Nifty moves closer to 25,000 after Budget day selloff | Closing Bell

Markets Beyond The Budget : What Next For Indian Investors ?

Nifty Braces For Further Pain As FIIs Return|Big Market Voices Decode STT Shock | Opening Bell Live

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell
You are already a Moneycontrol Pro user.